The Wall Street Journal
wsj.com
did:plc:i3fhjvvkbmirhyu4aeihhrnv
A late-stage trial showed that oral semaglutide significantly reduced blood sugar in 10- to 17-year-olds. on.wsj.com/4sP2wtc https://on.wsj.com/4sP2wtc
2026-04-23T10:09:33.447Z
Enable JavaScript to use Bluesky.
Learn more about Bluesky at bsky.social and atproto.com.